
Nuwellis, Inc. has installed three Aquadex SmartFlow systems at a leading pediatric hospital in Michigan, marking its first pediatric program in the state. This expansion supports the development of clinical protocols for precise fluid management in critically ill pediatric patients, aiming to grow Aquadex therapy adoption. The company is also pursuing FDA approval to extend Aquadex use to smaller pediatric patients, reinforcing its commitment to pediatric care. This move positions Nuwellis for long-term growth in the pediatric critical care market.